Ob jec tive: To eval u ate ep i de mi o log i cal as so ci a tions be tween self-re ported diet pill con sump tion and ma jor de pres sive ep i sodes (MDEs), us ing data from a large-scale, cross-sec tional sur vey of the Ca na dian pop u la tion.
A p pe tite sup pres sants have been re ported to cause de pressive symp toms, both as an ad verse ef fect of treat ment and dur ing with drawal. Due, how ever, to pro hib i tive sam ple size re quire ments, an as so ci a tion be tween these med i ca tions and de pres sive ep i sodes has not been con firmed in a gen eral pop u la tion sam ple. In Can ada, a large-scale, mul ti pur pose health sur vey con ducted by Sta tis tics Can ada, the Na tional Pop u la tion Health Sur vey (NPHS) (1), of fers an op por tu nity to eval u ate this as so ci a tion. Sta tis tics Can ada is Can ada's national sta tis ti cal agency; un der the Ca na dian Sta tis tics Act, it col lects sta tis ti cal in for ma tion on many as pects of Can ada's so ci ety and econ omy. The NPHS is a lon gi tu di nal sur vey that be gan data col lec tion in 1994 with a sam ple size of 17 626 sub jects. A sec ond wave of data col lec tion took place in 1996-1997. The 1996-1997 sur vey in cluded a larger sam ple be cause 3 prov inces (Al berta, Man i toba, and On tario) provided ex tra fund ing for sup ple men tal data col lec tion. This "buy-in" re sulted in a sam ple that in cluded 81 804 sub jects (1); it pre sented a unique op por tu nity to eval u ate cer tain as soci a tions in volv ing un com mon vari ables, in clud ing the pos sible as so ci a tions be tween the use of ap pe tite sup pres sants and ma jor de pres sive ep i sodes (MDEs).
Early re ports warned of de pres sion as a pos si ble ad verse effect of am phet amine use (2) . Mazindol, an ap pe tite sup pressant with a chem i cal struc ture re sem bling that of cy clic an ti de pres sants, has also been re ported to cause de pres sion (3). Fenfluramine, which was with drawn from the Ca na dian mar ket shortly af ter the 1996-1997 NPHS data col lec tion cycle, has a phenylethylamine chem i cal struc ture, but it is not clas si fied as a stim u lant be cause it tends to cause se da tion rather than stim u la tion. Emer gent de pres sive symp toms have been re ported fol low ing dis con tinu a tion of this med i ca tion (4) (5) (6) (7) (8) . Ep i de mi o log i cal as so ci a tions could also re sult from re verse causal mech a nisms (in which de pres sion leads to more fre quent use of ap pe tite sup pres sants). Sim i larly, they could re sult from "con found ing by in di ca tion" (9) , wherein the rea son for tak ing the med i ca tion (for ex am ple, obe sity), rather than the med i ca tion it self, gen er ates an artifactual appear ance of an ad verse drug ef fect.
Methods
The NPHS in cluded a pre dic tor for MDE called the Com posite In ter na tional Di ag nos tic In ter view Short Form for Ma jor De pres sion (CIDI-SFMD) (10) . This in stru ment con tains a set of mod i fied CIDI ques tions de signed to iden tify per sons likely to have ex pe ri enced an MDE in the pre ced ing year. As with other struc tured di ag nos tic in ter views, the CIDI-SFMD ques tions are ar ranged in a branched for mat. For ex am ple, a sub ject pro vid ing an af fir ma tive an swer to the ques tion " Dur ing the past 12 months, was there ever a time when you felt sad, blue, or de pressed for 2 weeks or more in a row?" would be asked to "think of the 2-week pe riod dur ing the past 12 months when these feel ings were the worst" and then asked "Dur ing that time, how long did these feel ings usu ally last?" MDE was iden ti fied when sub jects re ported 5 de pressive symp toms-at least 1 of which was de pressed mood or loss of in ter est -at spec i fied lev els of in ten sity and per sistence. The NPHS also in cluded a ques tion ask ing about the use of "diet pills" in the pre ced ing month. The ques tion had the fol low ing for mat: "In the past month, that is from (in sert: date one month prior to in ter view) to yes ter day, did you (insert: name) take any of the fol low ing med i ca tions?" This ques tion was fol lowed by a list of spe cific med i ca tions and med i ca tion classes, in clud ing diet pills. Sub jects who had taken one of these med i ca tions in the pre ced ing 2 days were asked to re trieve their pill bot tle(s), and the names of spe cific med i ca tions were re corded us ing a mod i fied An a tomic Thera peu tic Code (ATC) cod ing sys tem. The NPHS in ter view also in cluded a ques tion about per ceived weight: "Do you con sider your self over weight, un der weight or just about right?"
The to tal sam ple size for this com po nent of the sur vey was 81 804. The cur rent anal y sis was re stricted to mem bers of the sam ple who were over the age of 12 years at the time of the inter view (n = 73 402) and who re sponded to the "diet pill" ques tion and the ma jor de pres sion pre dic tor (n = 70 457). A de tailed de scrip tion of the sur vey's meth od ol ogy is avail able in a Gov ern ment of Can ada pub li ca tion (1). The com plex sam pling pro ce dures in the NPHS ne ces si tate the use of sampling weights in the anal y sis and boot strap vari ance es ti mation meth ods. All es ti mates and con fi dence in ter vals (CIs) pre sented here have em ployed these tech niques. All anal y sis used SAS Insitute tools (11) .
Results
The per cent age of NPHS re spon dents who re ported tak ing diet pills was 0.5% (95%CI, 0.4 to 0.6). More women (0.6%) than men (0.3%), but a sim i lar pro por tion of per sons un der the age of 45 (0.4%) and over 45 (0.5%), re ported tak ing these med i ca tions. Of 387 sub jects (120 men and 267 women) taking diet pills in the month pre ced ing the in ter view, 56 reported tak ing these in the 2 days pre ced ing the in ter view, and spe cific med i ca tion names were re corded for these sub jects. The most com mon ap pe tite sup pres sant was fenfluramine (n = 45), fol lowed by phentermine (n = 9) and un spec i fied med i ca tions listed as "other" (n = 5). Three sub jects were taking more than 1 of these med i ca tions.
In the 1996-1997 NPHS sam ple, the 12-month prev a lence of ma jor de pres sion was 4.2% (95%CI, 3.9% to 4.5%). Among per sons who re ported tak ing diet pills, the weighted 12-month pe riod prev a lence of ma jor de pres sion was ap proxi mately 4 times higher: 17.1% (95%CI, 8.6 to 25.6). The prev a lence dif fer ence was 13.0% (95%CI, 4.4 to 21.5). The prev a lence of MDE among men us ing these med i ca tions was too im pre cise for re lease (co ef fi cient of vari a tion 63.0, see [1] for a de scrip tion of data-re lease guide lines from Sta tis tics Can ada). Among women re port ing the use of these med i ca tions, the prev a lence of MDE was 24.1% (95%CI, 12.5 to 35.6). The prev a lence dif fer ence in women was 18.7% (95%CI, 7.2 to 30.2). The as so ci a tion be tween ap petite sup pres sants and MDE was highly sig nif i cant in sub jects un der the age of 45 years, where the prev a lence of MDE among ex posed sub jects was 27.2% (95%CI, 14.1 to 40.4). The data were too im pre cise to al low valid es ti ma tion in the older age cat e gory.
Per ceiving one self to be over weight was weakly, but sig nif icantly, as so ci ated with MDE: the prev a lence dif fer ence was 1.4% (95%CI, 0.8 to 2.0). Among sub jects who con sid ered them selves to be over weight, but who did not re port tak ing diet pills, the 12-month prev a lence of MDE was 5.0% (95%CI, 4.5 to 5.5), com pared with 3.7% (95%CI, 3.3 to 4.1) among sub jects who con sid ered them selves to be un derweight or "just about right." Among sub jects in this same cate gory who re ported tak ing diet pills, the prev a lence was 16.3% (95%CI, 6.1 to 26.5). These find ings do not sug gest that the ob served as so ci a tion re sulted from con found ing (that is, re flected an as so ci a tion with per ceived weight rather than with the med i ca tions). Only 0.9% (95%CI, 0.7 to 1.1) of subjects who per ceived them selves to be over weight re ported tak ing diet pills.
Conclusions
Sec ond ary anal y ses of data from gen eral health sur veys tend to be rel a tively crude be cause the data col lec tion in stru ments em ployed in these sur veys must be brief. Nev er the less, the large size of many gen eral health sur veys of fers an op por tunity to ex am ine ep i de mi o log i cal hy poth e ses that would be dif fi cult to eval u ate oth er wise. The anal y sis pre sented here pro vides the first ep i de mi o log i cal ev i dence of an as so ci a tion be tween ap pe tite sup pres sants and MDE in the gen eral pop ula tion. Be cause the anal y sis was based on cross-sec tional data, di rect causal in fer ence is not pos si ble. Also, com plete con trol of con found ing was not pos si ble be cause the rel atively low fre quency of diet pill use lim ited the ex tent of strati fi ca tion pos si ble (de spite the large sam ple size). Also, some po ten tial con found ers were not mea sured in the sur vey. For ex am ple, MDE is fre quently comorbid in per sons with eat ing dis or ders (12) , and be cause diet pills may also be fre quently used by peo ple with eat ing dis or ders (13), the as so ci a tion between diet pills and ma jor de pres sion may be con founded by these con di tions.
Be cause the time pe ri ods cov ered by the in stru ment eval u ating de pres sion (12 months) and med i ca tion use (1 month) were broad and only par tially over lap ping, it was not pos si ble to de ter mine whether ep i sodes of ma jor de pres sion oc curred prior to, co in ci dent with, or dur ing with drawal from the med ica tions. Also, in most cases, the name of the spe cific diet pill taken could not be iden ti fied. The avail able data sug gested that fenfluramine was the most com monly used ap pe tite suppres sant when data were col lected. Since fenfluramine is no lon ger avail able in Can ada, this has al most cer tainly changed since the time of data col lec tion. Ad di tional ep i de mi o log i cal data will be needed to de ter mine whether the with drawal of fenfluramine from the Ca na dian mar ket has al tered the as soci a tion be tween the use of ap pe tite sup pres sants and ma jor de pres sion. The ad vent of pe riph er ally act ing lipase in hib itors such as orlistat may also al ter these ep i de mi o log i cal as soci a tions. Be cause these drugs have min i mal ab sorp tion, they are un likely to have sub stan tial di rect ef fects within the central ner vous sys tem. They may, how ever, have po ten tially rel e vant in di rect ef fects (for ex am ple, by caus ing malabsorption of fat-sol u ble vi ta mins).
De spite these lim i ta tions, the re sults re ported here are striking be cause of the dra matic mag ni tude of the as so ci a tion between these med i ca tions and ma jor de pres sion. Pharmacoepidemiological data are of ten use ful for hy poth esis gen er a tion. For ex am ple, the pur ported as so ci a tion between re ser pine and ma jor de pres sion had an im pact on the de vel op ment of early neurobiological hy poth e ses about depres sion (14) . It is pos si ble that ap pe tite sup pres sants el e vate the risk of ma jor de pres sion through di rect neurobiological mech a nisms, as a fea ture of with drawal (the dis cor dance between a 1-month and 2-day mea sure of diet pill use in the NPHS sug gests that the med i ca tions are of ten used in ter mittently), or as an ar ti fact re sult ing from con found ing with variables not mea sured in this sur vey. Re verse causal mech a nisms are also pos si ble: de pres sive dis or ders may cause a more neg a tive eval u a tion of body im age, lead ing in directly to in creased ex po sure to diet pills. These find ings empha size the need for cau tion in the use of ap pe titesup pres sant med i ca tions and the need to fur ther eval u ate their as so ci a tion with de pres sion.
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